Skip to main content
NCBI home page
Neuroscience Bulletin logoLink to Neuroscience Bulletin
. 2014 Mar 14;30(2):359–366. doi: 10.1007/s12264-013-1415-y

Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer’s disease

Jian-Zhi Wang 1,✉, Zhi-Hao Wang 1, Qing Tian 1
PMCID: PMC5562660  PMID: 24627329

Abstract

Since abnormal post-translational modifications or gene mutations of tau have been detected in over twenty neurodegenerative disorders, tau has attracted widespread interest as a target protein. Among its various post-translational modifications, phosphorylation is the most extensively studied. It is recognized that tau hyperphosphorylation is the root cause of neurodegeneration in Alzheimer’s disease (AD); however, it is not clear how it causes neurodegeneration. Based on the findings that tau hyperphosphorylation leads to the escape of neurons from acute apoptosis and simultaneously impairs the function of neurons, we have proposed that the nature of AD neurodegeneration is the consequence of aborted apoptosis induced by tau phosphorylation. Therefore, proper manipulation of tau hyperphosphorylation could be promising for arresting AD neurodegeneration. In this review, the neuroprotective and neurodegenerative effects of tau hyperphosphorylation and our thoughts regarding their relationship are presented.

Keywords: Alzheimer’s disease, microtubule-associated protein tau, hyperphosphorylation, apoptosis, neurodegeneration

References

  • [1].Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, Wisniewski HM. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem. 1986;261:6084–6089. [PubMed] [Google Scholar]
  • [2].Hu YK, Wang X, Li L, Du YH, Ye HT, Li CY. MicroRNA-98 induces an Alzheimer’s disease-like disturbance by targeting insulin-like growth factor 1. Neurosci Bull. 2013;29:745–751. doi: 10.1007/s12264-013-1348-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3].Wang JZ, Liu F. Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol. 2008;85:148–175. doi: 10.1016/j.pneurobio.2008.03.002. [DOI] [PubMed] [Google Scholar]
  • [4].Tian Q, Wang J. Role of serine/threonine protein phosphatase in Alzheimer’s disease. Neurosignals. 2002;11:262–269. doi: 10.1159/000067425. [DOI] [PubMed] [Google Scholar]
  • [5].Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis. 2013;33(Suppl1):S123–139. doi: 10.3233/JAD-2012-129031. [DOI] [PubMed] [Google Scholar]
  • [6].Wang JZ, Grundke-Iqbal I, Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci. 2007;25:59–68. doi: 10.1111/j.1460-9568.2006.05226.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Sun XJ, Zhao L, Zhao N, Pan XL, Fei GQ, Jin LR, et al. Benfotiamine prevents increased beta-amyloid production in HEK cells induced by high glucose. Neurosci Bull. 2012;28:561–566. doi: 10.1007/s12264-012-1264-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Zhu LQ, Wang SH, Liu D, Yin YY, Tian Q, Wang XC, et al. Activation of glycogen synthase kinase-3 inhibits longterm potentiation with synapse-associated impairments. J Neurosci. 2007;27:12211–12220. doi: 10.1523/JNEUROSCI.3321-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Zhu LQ, Liu D, Hu J, Cheng J, Wang SH, Wang Q, et al. GSK-3 beta inhibits presynaptic vesicle exocytosis by phosphorylating P/Q-type calcium channel and interrupting SNARE complex formation. J Neurosci. 2010;30:3624–3633. doi: 10.1523/JNEUROSCI.5223-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Liu SJ, Zhang AH, Li HL, Wang Q, Deng HM, Netzer WJ, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem. 2003;87:1333–1344. doi: 10.1046/j.1471-4159.2003.02070.x. [DOI] [PubMed] [Google Scholar]
  • [11].Xiong YS, Wang DL, Tan L, Wang X, Chen LM, Gong CX, et al. Inhibition of glycogen synthase kinase-3 reverses tau hyperphosphorylation induced by pin1 down-regulation. CNS Neurol Disord Drug Targets. 2013;12:436–443. doi: 10.2174/1871527311312030016. [DOI] [PubMed] [Google Scholar]
  • [12].Yin J, Liu YH, Xu YF, Zhang YJ, Chen JG, Shu BH, et al. Melatonin arrests peroxynitrite-induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain. J Pineal Res. 2006;41:124–129. doi: 10.1111/j.1600-079X.2006.00343.x. [DOI] [PubMed] [Google Scholar]
  • [13].Peng CX, Hu J, Liu D, Hong XP, Wu YY, Zhu LQ, et al. Disease-modified glycogen synthase kinase-3beta intervention by melatonin arrests the pathology and memory deficits in an Alzheimer’s animal model. Neurobiol Aging. 2013;34:1555–1563. doi: 10.1016/j.neurobiolaging.2012.12.010. [DOI] [PubMed] [Google Scholar]
  • [14].Zhang YJ, Xu YF, Liu YH, Yin J, Wang JZ. Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase-3beta activation. FEBS Lett. 2005;579:6230–6236. doi: 10.1016/j.febslet.2005.09.095. [DOI] [PubMed] [Google Scholar]
  • [15].Li XH, Du LL, Cheng XS, Jiang X, Zhang Y, Lv BL, et al. Glycation exacerbates the neuronal toxicity of beta-amyloid. Cell Death Dis. 2013;4:e673. doi: 10.1038/cddis.2013.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Li XH, Lv BL, Xie JZ, Liu J, Zhou XW, Wang JZ. AGEs induce Alzheimer-like tau pathology and memory deficit via RAGEmediated GSK-3 activation. Neurobiol Aging. 2012;33:1400–1410. doi: 10.1016/j.neurobiolaging.2011.02.003. [DOI] [PubMed] [Google Scholar]
  • [17].Liu YH, Wei W, Yin J, Liu GP, Wang Q, Cao FY, et al. Proteasome inhibition increases tau accumulation independent of phosphorylation. Neurobiol Aging. 2009;30:1949–1961. doi: 10.1016/j.neurobiolaging.2008.02.012. [DOI] [PubMed] [Google Scholar]
  • [18].Wang ZF, Li HL, Li XC, Zhang Q, Tian Q, Wang Q, et al. Effects of endogenous beta-amyloid overproduction on tau phosphorylation in cell culture. J Neurochem. 2006;98:1167–1175. doi: 10.1111/j.1471-4159.2006.03956.x. [DOI] [PubMed] [Google Scholar]
  • [19].Liu SJ, Zhang JY, Li HL, Fang ZY, Wang Q, Deng HM, et al. Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain. J Biol Chem. 2004;279:50078–50088. doi: 10.1074/jbc.M406109200. [DOI] [PubMed] [Google Scholar]
  • [20].Hong XP, Peng CX, Wei W, Tian Q, Liu YH, Yao XQ, et al. Essential role of tau phosphorylation in adult hippocampal neurogenesis. Hippocampus. 2010;20:1339–1349. doi: 10.1002/hipo.20712. [DOI] [PubMed] [Google Scholar]
  • [21].Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K. Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem. 1995;65:732–738. doi: 10.1046/j.1471-4159.1995.65020732.x. [DOI] [PubMed] [Google Scholar]
  • [22].Wang JZ, Gong CX, Zaidi T, Grundke-Iqbal I, Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem. 1995;270:4854–4860. doi: 10.1074/jbc.270.9.4854. [DOI] [PubMed] [Google Scholar]
  • [23].Wang JZ, Grundke-Iqbal I, Iqbal K. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res Mol Brain Res. 1996;38:200–208. doi: 10.1016/0169-328X(95)00316-K. [DOI] [PubMed] [Google Scholar]
  • [24].Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer’s disease. J Biol Chem. 2000;275:5535–5544. doi: 10.1074/jbc.275.8.5535. [DOI] [PubMed] [Google Scholar]
  • [25].Sun L, Liu SY, Zhou XW, Wang XC, Liu R, Wang Q, et al. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience. 2003;118:1175–1182. doi: 10.1016/S0306-4522(02)00697-8. [DOI] [PubMed] [Google Scholar]
  • [26].Yang Y, Yang XF, Wang YP, Tian Q, Wang XC, Li HL, et al. Inhibition of protein phosphatases induces transport deficits and axonopathy. J Neurochem. 2007;102:878–886. doi: 10.1111/j.1471-4159.2007.04603.x. [DOI] [PubMed] [Google Scholar]
  • [27].Xiong Y, Jing XP, Zhou XW, Wang XL, Yang Y, Sun XY, et al. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation. Neurobiol Aging. 2013;34:745–756. doi: 10.1016/j.neurobiolaging.2012.07.003. [DOI] [PubMed] [Google Scholar]
  • [28].Yu G, Yan T, Feng Y, Liu X, Xia Y, Luo H, et al. Ser9 phosphorylation causes cytoplasmic detention of I2PP2A/SET in Alzheimer disease. Neurobiol Aging. 2013;34:1748–1758. doi: 10.1016/j.neurobiolaging.2012.12.025. [DOI] [PubMed] [Google Scholar]
  • [29].Chai GS, Jiang X, Ni ZF, Ma ZW, Xie AJ, Cheng XS, et al. Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. J Neurochem. 2013;124:388–396. doi: 10.1111/jnc.12094. [DOI] [PubMed] [Google Scholar]
  • [30].Cheng XS, Zhao KP, Jiang X, Du LL, Li XH, Ma ZW, et al. Nmnat2 attenuates Tau phosphorylation through activation of PP2A. J Alzheimers Dis. 2013;36:185–195. doi: 10.3233/JAD-122173. [DOI] [PubMed] [Google Scholar]
  • [31].Liu XP, Zheng HY, Qu M, Zhang Y, Cao FY, Wang Q, et al. Upregulation of astrocytes protein phosphatase-2A stimulates astrocytes migration via inhibiting p38 MAPK in tg2576 mice. Glia. 2012;60:1279–1288. doi: 10.1002/glia.22347. [DOI] [PubMed] [Google Scholar]
  • [32].Yao XQ, Zhang XX, Yin YY, Liu B, Luo DJ, Liu D, et al. Glycogen synthase kinase-3beta regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src. Biochem J. 2011;437:335–344. doi: 10.1042/BJ20110347. [DOI] [PubMed] [Google Scholar]
  • [33].Liu GP, Zhang Y, Yao XQ, Zhang CE, Fang J, Wang Q, et al. Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiol Aging. 2008;29:1348–1358. doi: 10.1016/j.neurobiolaging.2007.03.012. [DOI] [PubMed] [Google Scholar]
  • [34].Wang JZ, Grundke-Iqbal I, Iqbal K. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer’s disease. Nat Med. 1996;2:871–875. doi: 10.1038/nm0896-871. [DOI] [PubMed] [Google Scholar]
  • [35].Li X, Lu F, Wang JZ, Gong CX. Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting. Eur J Neurosci. 2006;23:2078–2086. doi: 10.1111/j.1460-9568.2006.04735.x. [DOI] [PubMed] [Google Scholar]
  • [36].Han J, Wang XF, Yao HI, Gao C, Li F, Zhang BY, et al. Prion protein inhibits tau-mediated microtubule formation. Neurosci Bull. 2005;21(6):398–403. [Google Scholar]
  • [37].Alonso AC, Zaidi T, Grundke-Iqbal I, Iqbal K. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci U S A. 1994;91:5562–5566. doi: 10.1073/pnas.91.12.5562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Wang JZ, Wu Q, Smith A, Grundke-Iqbal I, Iqbal K. Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase. FEBS Lett. 1998;436:28–34. doi: 10.1016/S0014-5793(98)01090-4. [DOI] [PubMed] [Google Scholar]
  • [39].Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K. Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci U S A. 2001;98:6923–6928. doi: 10.1073/pnas.121119298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Salehi A, Delcroix JD, Mobley WC. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends Neurosci. 2003;26:73–80. doi: 10.1016/S0166-2236(02)00038-3. [DOI] [PubMed] [Google Scholar]
  • [41].Xiao AW, He J, Wang Q, Luo Y, Sun Y, Zhou YP, et al. The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer’s disease. Neurosci Bull. 2011;27:287–299. doi: 10.1007/s12264-011-1736-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Spittaels K, Van den Haute C, Van Dorpe J, Bruynseels K, Vandezande K, Laenen I, et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol. 1999;155:2153–2165. doi: 10.1016/S0002-9440(10)65533-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [43].Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA, Massachi S, et al. Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron. 2002;34:509–519. doi: 10.1016/S0896-6273(02)00706-7. [DOI] [PubMed] [Google Scholar]
  • [44].Perez M, Hernandez F, Lim F, Diaz-Nido J, Avila J. Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. J Alzheimers Dis. 2003;5:301–308. doi: 10.3233/jad-2003-5405. [DOI] [PubMed] [Google Scholar]
  • [45].Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A. 2005;102:6990–6995. doi: 10.1073/pnas.0500466102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Mori H, Kondo J, Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer’s disease. Science. 1987;235:1641–1644. doi: 10.1126/science.3029875. [DOI] [PubMed] [Google Scholar]
  • [47].Ren QG, Liao XM, Wang ZF, Qu ZS, Wang JZ. The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation. FEBS Lett. 2006;580:2503–2511. doi: 10.1016/j.febslet.2006.03.073. [DOI] [PubMed] [Google Scholar]
  • [48].Ren QG, Liao XM, Chen XQ, Liu GP, Wang JZ. Effects of tau phosphorylation on proteasome activity. FEBS Lett. 2007;581:1521–1528. doi: 10.1016/j.febslet.2007.02.065. [DOI] [PubMed] [Google Scholar]
  • [49].Keck S, Nitsch R, Grune T, Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer’s disease. J Neurochem. 2003;85:115–122. doi: 10.1046/j.1471-4159.2003.01642.x. [DOI] [PubMed] [Google Scholar]
  • [50].Morsch R, Simon W, Coleman PD. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol. 1999;58:188–197. doi: 10.1097/00005072-199902000-00008. [DOI] [PubMed] [Google Scholar]
  • [51].Spires TL, Orne JD, SantaCruz K, Pitstick R, Carlson GA, Ashe KH, et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol. 2006;168:1598–1607. doi: 10.2353/ajpath.2006.050840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci. 2002;22:9340–9351. doi: 10.1523/JNEUROSCI.22-21-09340.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [53].Arendt T, Stieler J, Strijkstra AM, Hut RA, Rudiger J, Van der Zee EA, et al. Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci. 2003;23:6972–6981. doi: 10.1523/JNEUROSCI.23-18-06972.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [54].Zhou F, Zhu X, Castellani RJ, Stimmelmayr R, Perry G, Smith MA, et al. Hibernation, a model of neuroprotection. Am J Pathol. 2001;158:2145–2151. doi: 10.1016/S0002-9440(10)64686-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [55].Zhang DL, Chen YQ, Jiang X, Ji TT, Mei B. Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice. Neurosci Bull. 2009;25:131–137. doi: 10.1007/s12264-009-0114-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Liu GP, Wei W, Zhou X, Zhang Y, Shi HH, Yin J, et al. I(2)(PP2A) regulates p53 and Akt correlatively and leads the neurons to abort apoptosis. Neurobiol Aging. 2012;33:254–264. doi: 10.1016/j.neurobiolaging.2010.01.016. [DOI] [PubMed] [Google Scholar]
  • [57].Li HL, Wang HH, Liu SJ, Deng YQ, Zhang YJ, Tian Q, et al. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer’s neurodegeneration. Proc Natl Acad Sci U S A. 2007;104:3591–3596. doi: 10.1073/pnas.0609303104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [58].Wang ZF, Yin J, Zhang Y, Zhu LQ, Tian Q, Wang XC, et al. Overexpression of tau proteins antagonizes amyloid-beta-potentiated apoptosis through mitochondria-caspase-3 pathway in N2a cells. J Alzheimers Dis. 2010;20:145–157. doi: 10.3233/JAD-2010-1351. [DOI] [PubMed] [Google Scholar]
  • [59].Wang HH, Li HL, Liu R, Zhang Y, Liao K, Wang Q, et al. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors. J Alzheimers Dis. 2010;21:167–179. doi: 10.3233/JAD-2010-091279. [DOI] [PubMed] [Google Scholar]
  • [60].Liu XA, Liao K, Liu R, Wang HH, Zhang Y, Zhang Q, et al. Tau dephosphorylation potentiates apoptosis by mechanisms involving a failed dephosphorylation/activation of Bcl-2. J Alzheimers Dis. 2010;19:953–962. doi: 10.3233/JAD-2010-1294. [DOI] [PubMed] [Google Scholar]
  • [61].Gu XM, Huang HC, Jiang ZF. Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease. Neurosci Bull. 2012;28:631–640. doi: 10.1007/s12264-012-1270-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neuroscience Bulletin are provided here courtesy of Springer

RESOURCES